Satish Marukurthi – Croissance Clinical Research (Ccr)
View Detailed Executive Profile →Professional Overview
- Satish Marukurthi founded Croissance Clinical Research (CCR) in May 2012, marking the beginning of a venture focused on clinical research services.
- Satish served as the Chief Executive Officer of CCR from July 2013 until October 2023, steering the company through its growth phase and strategic development.
- Prior to leading CCR, Satish held the position of Vice President - Clinical Research & Allied Services at ClinAsia Labs Pvt. Ltd. from November 2011 to May 2013, contributing to clinical trial management and operational excellence.
- In the earlier career phase, Satish acquired experience as General Manager - Business Development at Sristek Consulting Pvt. Ltd. from February 2010 to November 2011, focusing on business expansion and client relations.
- Satish also worked as Sr Business Development Manager at Asian Clinical Trials, a division of Suven Life Sciences Ltd., starting in August 2008 and concluding in January 2010, enhancing market outreach and service offerings.
- Under Satish's leadership, CCR has positioned itself as a reputable organization in the clinical research sector, contributing to numerous successful trials and collaborations.
- Satish has navigated various challenges in the clinical research industry, including regulatory changes and market competition, ensuring CCR remains compliant and competitive.
- Recognition of CCR's work during Satish's tenure has led to partnerships with several pharmaceutical companies and research organizations, amplifying the organization's impact in the field.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| ClinAsia Labs Pvt. Ltd. | Vice President - Clinical Research & Allied Services | Nov 2011 – May 2013 |
| Croissance Clinical Research | Chief Executive Officer | Jul 2013 – Oct 2023 |
| Sristek Consulting Pvt. Ltd | General Manager - Business Development Manager | Feb 2010 – Nov 2011 |
| Asian Clinical Trials, A Division of Suven Life Sciences Ltd. | Sr Business Development Manager | Aug 2008 – Jan 2010 |
| Croissance Clinical Research | Founder and CEO | May 2012 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Croissance Clinical Research (Ccr) corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Satish Marukurthi's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Croissance Clinical Research (Ccr)'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)